Format

Send to

Choose Destination
Int J Med Sci. 2018 Jan 1;15(1):36-45. doi: 10.7150/ijms.21666. eCollection 2018.

Ethical and Safety Issues of Stem Cell-Based Therapy.

Author information

1
University of Kragujevac, Serbia, Faculty of Medical Sciences, Department of Microbiology and Immunology, Center for Molecular Medicine and Stem Cell Research.
2
University of Kragujevac, Serbia, Faculty of Medical Sciences, Department of Genetics.
3
University of Kragujevac, Serbia, Faculty of Medical Sciences, Department of Histology and Embryology.
4
Institute of Genetic Medicine, Newcastle University, UK.
5
Institute of Anatomy, University of Bern, Bern, Switzerland.

Abstract

Results obtained from completed and on-going clinical studies indicate huge therapeutic potential of stem cell-based therapy in the treatment of degenerative, autoimmune and genetic disorders. However, clinical application of stem cells raises numerous ethical and safety concerns. In this review, we provide an overview of the most important ethical issues in stem cell therapy, as a contribution to the controversial debate about their clinical usage in regenerative and transplantation medicine. We describe ethical challenges regarding human embryonic stem cell (hESC) research, emphasizing that ethical dilemma involving the destruction of a human embryo is a major factor that may have limited the development of hESC-based clinical therapies. With previous derivation of induced pluripotent stem cells (iPSCs) this problem has been overcome, however current perspectives regarding clinical translation of iPSCs still remain. Unlimited differentiation potential of iPSCs which can be used in human reproductive cloning, as a risk for generation of genetically engineered human embryos and human-animal chimeras, is major ethical issue, while undesired differentiation and malignant transformation are major safety issues. Although clinical application of mesenchymal stem cells (MSCs) has shown beneficial effects in the therapy of autoimmune and chronic inflammatory diseases, the ability to promote tumor growth and metastasis and overestimated therapeutic potential of MSCs still provide concerns for the field of regenerative medicine. This review offers stem cell scientists, clinicians and patient's useful information and could be used as a starting point for more in-depth analysis of ethical and safety issues related to clinical application of stem cells.

KEYWORDS:

embryonic stem cells; induced pluripotent stem cells; mesenchymal stem cells; stem cell-based therapy.

PMID:
29333086
PMCID:
PMC5765738
DOI:
10.7150/ijms.21666
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Ivyspring International Publisher Icon for PubMed Central
Loading ...
Support Center